Compare clinical trial landscapes across conditions and treatments in the UK
Explore how clinical trial availability, treatment approaches, and research opportunities differ between related conditions and treatment types. Each comparison provides UK-specific trial counts and practical guidance for patients.
Breast cancer has more trial options due to higher incidence and established biomarker testing. Ovarian cancer trials fo...
Lung cancer has far more trials driven by molecular subtyping. Mesothelioma has fewer but highly targeted trials, often ...
Prostate cancer trials often focus on treatment timing and sequencing. Colorectal cancer trials are more biomarker-drive...
Melanoma is a flagship for immunotherapy trials. Head and neck cancer trials are more diverse, covering surgical, radiat...
Both upper GI cancers share some treatment approaches but have different risk factors and surgical considerations. Oesop...
Bladder cancer trials span BCG alternatives to radical surgery options. Kidney cancer trials are dominated by systemic t...
Brain cancer trials face unique challenges with the blood-brain barrier. Head and neck cancer trials are more diverse in...
Blood cancer trials include cellular therapies (CAR-T) and transplant approaches. Melanoma trials pioneered checkpoint i...
Pancreatic cancer has fewer trials due to poor prognosis and difficulty in early detection. Colorectal cancer has more b...
SCLC has far fewer trials and treatment options. NSCLC has become a model for precision oncology with biomarker-guided t...
Both are hormone-driven cancers with established screening. Breast cancer has more molecular subtypes driving trial dive...
MS has more active DMT trials due to clearer immune-mediated mechanisms. Parkinson's trials are more challenging due to ...
Alzheimer's trials are long-duration and focus on cognitive decline slowing. Epilepsy trials are shorter, focusing on se...
Migraine trials focus on quality of life and attack frequency. Stroke trials have higher stakes with acute intervention ...
Immunotherapy can produce durable long-term responses but only works in a subset of patients. Chemotherapy is more broad...
Targeted therapies require specific mutations. Immunotherapy depends on the tumour's immune environment. Both are precis...
Surgery provides immediate tumour removal but requires fitness for anaesthesia. Radiation avoids surgery but requires mu...
Hormone therapy is specific to hormone-sensitive cancers and is often long-term. Targeted therapy can apply to many canc...
Gene therapy targets the root genetic cause but is early-stage. Stem cell transplant is proven for blood cancers but car...
Earlier phases offer novel treatments but with more uncertainty about benefit. Phase 3 trials provide the most reliable ...